ViGenCell, Inc. engages in the research and development of natural science and engineering. It specializes in immune cell therapy. The company was founded on February 1, 2013 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company